Original paper
Calcium channel blocker exposure and psoriasis risk: Pharmacovigilance investigation and literature data
Abstract
Evidence regarding a possible association between psoriatic manifestations and use of calcium channel blockers (CCBs) is sparse. Currently, psoriatic manifestations are not listed in the summary of product characteristics (SmPC) of CCBs. In this context, we aimed to investigate the association between psoriasis and CCB exposure. We reviewed spontaneous reports recorded in the French national pharmacovigilance database (FPVD) between 1985 and...
Paper Details
Title
Calcium channel blocker exposure and psoriasis risk: Pharmacovigilance investigation and literature data
Published Date
Jan 1, 2021
Journal
Volume
76
Issue
1
Pages
5 - 11
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History